Literature DB >> 3494885

Fifteen hundred coronary reoperations. Results and determinants of early and late survival.

B W Lytle, F D Loop, D M Cosgrove, P C Taylor, M Goormastic, W Peper, C C Gill, L A Golding, R W Stewart.   

Abstract

Fifteen hundred consecutive patients undergoing a first reoperation for coronary revascularization were reviewed to determine early and late results and predictors of survival. Patients were subdivided into cohorts on the basis of the year of reoperation: Group A (1967 to 1978, 436 patients); Group B (1979 to 1981, 439 patients); and Group C (1982 to 1984, 625 patients). Overall operative mortality was 3.4% (51 deaths): 4.6%, 2.3%, and 3.4% for Groups A, B, and C, respectively. Group C had significantly more women (p = 0.01) and patients with triple-vessel disease, left main coronary artery stenosis (greater than or equal to 50%), abnormal left ventricular function, age greater than or equal to 70 years, and graft failure as a surgical indication (all p less than 0.001). The mean interval between operations increased from 50 months for Group A to 84 months for Group C. At reoperation, Group C patients received more grafts, more internal mammary artery grafts, and had a higher prevalence of complete revascularization (all p less than 0.001). Univariate and multivariate analyses identified left main stenosis (p less than 0.0001), Class III or IV symptoms (p = 0.0002), advanced age (p = 0.0006), Group A (p = 0.02), and incomplete revascularization (p = 0.004) as predictors of increased in-hospital mortality. Follow-up of in-hospital survivors (mean interval 54 months, range 13 to 171 months) documented a 5 year survival rate of 90% and a 10 year survival rate of 75%. Multivariate testing identified advanced age (p less than 0.0001), hypertension (p less than 0.0001), and abnormal left ventricular function (p less than 0.0001) as predictors of decreased late survival.

Entities:  

Mesh:

Year:  1987        PMID: 3494885

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  21 in total

1.  The string phenomenon: an important cause of internal mammary artery graft failure.

Authors:  R P Villareal; V S Mathur
Journal:  Tex Heart Inst J       Date:  2000

Review 2.  Pump or no pump for coronary artery bypass: current best available evidence.

Authors:  Shahzad G Raja
Journal:  Tex Heart Inst J       Date:  2005

3.  How I choose conduits and configure grafts for my patients-rationales and practices.

Authors:  Allen Cheng; Mark S Slaughter
Journal:  Ann Cardiothorac Surg       Date:  2013-07

4.  Coronary artery bypass surgery.

Authors:  A J Bryan; S W Kendall; S R Large; J Wallwork
Journal:  BMJ       Date:  1990-06-16

Review 5.  Coronary artery bypass surgery.

Authors:  E W Cameron; W S Walker
Journal:  BMJ       Date:  1990-05-12

6.  Reoperation for coronary atherosclerosis. Changing practice in 2509 consecutive patients.

Authors:  F D Loop; B W Lytle; D M Cosgrove; E L Woods; R W Stewart; L A Golding; M Goormastic; P C Taylor
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

Review 7.  Reoperation after coronary bypass grafting.

Authors:  A H Menkis; S D Carley; T M Clough
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

8.  Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts.

Authors:  Rafał A Januszek; Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Dariusz Dudek; Stanisław Bartuś
Journal:  Cardiol J       Date:  2018-04-19       Impact factor: 2.737

Review 9.  Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

Authors:  R Davis; R Whittington
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

10.  Early and long term results of re-operation for coronary artery disease.

Authors:  E S Akl; E Ozdogan; S K Ohri; M Barbir; J A Gaer; A G Mitchell; M H Yacoub
Journal:  Br Heart J       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.